Acknowledgement

ADA 2022 Highlights Editor

Dana Dabelea, MD, PhD
Colorado School of Public Health
Denver, CO, USA

Interviews

Alexander Blood, MD
Brigham and Women's Hospital
Boston, MA, USA

Alan Delamater, PhD
University of Miami Miller School of Medicine
Miami, FL, USA

Stefano Del Prato, MD
EASD President

Robert A. Gabbay, MD, PhD
ADA Chief Science & Medical Officer

Phyo Htoo, MD, PhD
Brigham and Women's Hospital
Boston, MA, USA

Ram Jagannathan, PhD
Emory University
Atlanta, GA, USA

Ania M Jastreboff, MD, PhD
Yale University School of Medicine
New Haven, CT, USA

Hiddo Lambers Heerspink, PhD
University Medical Center Groningen
Groningen, Netherlands

Richard David Leslie, MBBS, MRCS, MD, FRCP, FAoP
Blizard Institute
London, UK

Peter Rossing, MD, DMSc
Steno Diabetes Center
Copenhagen, Denmark

Elizabeth Speliotes, MD, PhD, MPH
University of Michigan
Ann Arbor, MI, USA

R. Paul Wadwa, MD
University of Colorado Anschutz Medical Campus
Aurora, CO, USA

Expert Overviews

Pablo Aschner, MD, MD, MHS
Javeriana University, San Ignacio University Hospital
Bogotá, Colombia

Eda Cengiz, MD, MHS
University of California, San Francisco
San Francisco, CA, USA

Vivian Fonseca, MD
Tulane University School of Medicine
New Orleans, LA, USA

Raghu Mirmira, MD, PhD
University of Chicago
Chicago, IL, USA

Naveed Sattar, MD, PhD
University of Glasgow
Glasgow, UK

Expert commentaries

Guy Todd Alonso, MD
Pediatric Clinic, Barbara Davis Center
University of Colorado, Denver, CO, USA

Rodolfo Galindo, MD
Emory University School of Medicine
Atlanta, GA, USA

Ildico Lingvay, MD, MPH, MSCS
University of Texas Southwestern Medical Center
Dallas, TX

Katherine Sauder, PhD
University of Colorado Anschutz Medical Campus
Aurora, CO USA

Amy Shah, MD, MS
Cincinnati Children's Hospital Medical Center & the University of Cincinnati
Cincinnati, OH, USA

Staff

Medical Writers

Marco Gallo, MD Endocrine and Metabolic Complications of Cancer - Oncological Endocrinology Antonio e Biagio e Cesare Arrigo Hospital of Alessandria Alessandria, Italy

Marie Farrow
Synthesis Editorial Ltd

All rights reserved. Neither this publication nor any part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of Infomedica.

The content published in this website are the Highlights from the American Diabetes Association’s 82nd Scientific Sessions.

ADA 2022 Highlights content is made available to an international audience through a licensing agreement between Infomedica and the American Diabetes Association.

Developed by
Infomedica | Medical Education & Information
E-mail: info@infomedica.com
Website: www.infomedica.com

Disclaimer

In the course of covering medical congresses, Infomedica, the Publisher, may report on emerging technologies, techniques, and therapies. These reports may discuss drug and device applications that are either not approved by the appropriate regulatory body and/or the national or international Agency (Food and Drug Administration, European Medicines Agency, etc.) are not considered to be within the current standard guidelines for the practice of medicine. The Publisher does not assume any legal liability or responsibility for the accuracy, completeness, or usefulness of the information supplied nor for any opinion expressed in the publication. The Publisher, its agents, and employees will not be liable for any loss or damage arising directly or indirectly from the possession, publication, use of, or reliance on information obtained from the publication. It is provided in good faith without express or implied warranty. Reference to any specific commercial product or service does not imply endorsement or recommendation by the Publisher. In the interest of balance and transparency, no brand names are used in any of the reports. Commercial companies are not permitted any influence on editorial content. Advertisers and sponsors do not see editorial content prior to publication.

关于ADA

反馈

音频图书馆